Douglas Sborov

Douglas W Sborov, MD

University of Utah

Moderator

Biography

Douglas Sborov, MD MS is a Professor of Medicine at the University of Utah (UU) – Huntsman Cancer Institute (HCI), Department of Internal Medicine - Division of Hematology and Hematologic Malignancies. He is also the Craig and Marianne Mecham Endowed Chair in Hematological Oncology and is an Adjunct Professor in the Departments of Molecular Pharmaceutics and Biomedical Engineering. He is the Director of the HCI Hematology Disease Center and Plasma Cell Dyscrasias (PCD) Program, Co-Leader of the Hematologic Malignancies Clinical Trials Research Group, and member of the HCI Experimental Therapeutics Program and International Myeloma Working Group (IMWG). He is an elected Huntsman Translational Scholar, member of the Alliance Myeloma Committee, and Society of Medical Oncology (SUMO) Board member.

Financial Disclosure

GSK, BMS, Regeneron, J&J, Pfizer, Opna Bio, Legend Biotech, Sanofi, Karyopharm

Advisor